RISK WARNING: Your capital is at risk. The risks include: the lack of liquidity in this market in terms of being able to realise investments and the loss of the value of investment. When you invest any loss in value will not be covered by the Financial Services Compensation Scheme. Please read FULL risk warning.
Living With develops smart condition management apps, used by healthcare providers which improve patient outcomes and save costs.
A pledge is not a commitment. You will be asked to confirm in the next section.
There is a large and diverse set of healthcare professionals, clinics and providers who want to launch their own condition management products for patients and end users across 1000’s of conditions, both in the UK and internationally.
This includes insurers, pharmaceutical companies, researchers, hospitals, private clinics, hospital consultants, allied health professionals and charities. In the UK there are 220 NHS and 200+ private hospitals, 200+ CCG’s, 47,816 hospital consultants and 172,688 allied health professionals. This is growing year on year. There are 1.8 million physicians working in the EU and over 7000 hospitals.
- Squeezy the UK’s top paid medical app with 127,000 downloads, to help patients to do their pelvic floor exercises
- Living With Pelvic Health (LWPH) for physiotherapy, enables clinics to provide patients with bladder and bowel issues with a free and connected version of Squeezy and monitor them remotely. It is live in 12 NHS Trusts and 4 private clinics (UK & CH) and is now extending into higher value conditions e.g. urology and colorectal.
- Living With Rheumatoid Arthritis (LWRA), is in 1 NHS trust, and going live in 2 more. The company has also won a £320k Innovate UK grant to develop an AI based flare profiler.
- Living With Lupus (LWL) is in development with a pharma company, for use internationally in multiple languages.
The company is currently raising a 2nd round of £350,000 in EIS funding to develop a first version of its build-your-own platform, get a 3rd condition live, namely Living With Lung cancer, with Bart’s NHS Trust and finish the next stage of LWRA product development to close some new paying customers. The company is planning to do an institutional fundraise in late 2019.
The company expects to earn £1.07m of revenues by year end March 31st, 2019.
“The healthcare market is moving ever faster towards enabling patients to take more control of the management and treatment of their conditions and to providing opportunities for ‘treatment at a distance’. With their long experience with Squeezy, Living With is well placed to benefit from this trend and to develop the products that enable this. Getting into 12 NHS Trusts in 12 months and developing the breadth of prospects that they have in their pipeline, is testament to their ability to grow a company. The business is eminently scalable, both by product and geography.” -- Lars McBride , 1st Round Investor
Investment Focus: Equity and Debt
About: Envestors is a FCA regulated corporate finance adviser in the UK and operates an international network of sophisticated investors investing a minimum of £25,000 in high growth unquoted companies seeking £250,000 to £2m in equity funding. Envestors是英国受FCA监管的企业金融顾问同时运营着一个国际化的资深投资人网络，为高速发展的公司寻求最低为£25,000的现金投资，£250,000到£2m的股权投资。
Contact Name: Oliver Woolley
Registered InvestorsOver 1000
Investment through platformOver £100m